Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models
VAV1 is a hematopoietic signal transducer that possesses a GDP/GTP nucleotide exchange factor (GEF) that is tightly regulated by tyrosine phosphorylation, along with adapter protein domains, such as SH2 and SH3. Research on <i>VAV1</i> has advanced over the years since its discovery as a...
Main Authors: | Batel Shalom, Yaser Salaymeh, Matan Risling, Shulamit Katzav |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/9/1276 |
Similar Items
-
Vav1 Promotes B-Cell Lymphoma Development
by: Batel Shalom, et al.
Published: (2022-03-01) -
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
by: Myriam Cuadrado, et al.
Published: (2021-09-01) -
Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer
by: Luis Francisco Lorenzo-Martín, et al.
Published: (2020-09-01) -
Role of Vav1, a hematopoietic signal transduction molecule, as an adaptor protein in health and disease
by: Shulamit Katzav
Published: (2023-04-01) -
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
by: Yuriko Saiki, et al.
Published: (2021-12-01)